Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Standal%2C+T%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Standal%2C+T%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2014
Mark Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Olsen, O E ; Wader, K F ; Misund, K ; Våtsveen, T K ; Rø, T B ; Mylin, A K ; Turesson, Ingemar ^LU ; Størdal, B F ; Moen, S H and Standal, T , et al. (2014) In Blood Cancer Journal 4(Mar 21). p.196-196
- Contribution to journal › Article
2004
Mark Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
Standal, T ; Hjorth-Hansen, H ; Rasmussen, T ; Dahl, IMS ; Lenhoff, Stig ^LU ; Brenne, AT ; Seidel, C ; Baykov, V ; Waage, A and Borset, M , et al. (2004) In Haematologica 89(2). p.174-182
- Contribution to journal › Article
2002
Mark Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
Standal, T ; Borset, M ; Lenhoff, S ; Wisloff, F ; Stordal, B ; Sundan, A ; Waage, A ; Seidel, C ; Turesson, Ingemar ^LU and Westin, Jan ^LU (2002) In Blood 100(12). p.3925-3929
- Contribution to journal › Article